Drugs / Dianeal
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy5 trials | ||||||
| Phase 3 | NCT03994471 Comparator | Dec 2022 → Dec 2026 expected | end stage renal failure | Iperboreal Pharma Srl | Recruiting | No outcome recorded |
| Phase 3 | NCT01219959 Comparator | Oct 2010 → Jul 2011 | diabetes mellitus, end stage renal failure | Vantive Health LLC | Completed | Met primary |
| Phase 3 | NCT00567398 Comparator | Apr 2008 → Jul 2011 | diabetes mellitus, end stage renal failure | Vantive Health LLC | Completed | Met primary |
| Phase 4 | NCT00567489 Comparator | Jan 2008 → Jul 2011 | diabetes mellitus, end stage renal failure | Vantive Health LLC | Completed | Met primary |
| — | NCT06872645 Comparator | Oct 2025 → Jun 2028 expected | — | Yale University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dianeal | “1.5% standard peritoneal dialysis (PD) fluid (Dianeal 1.5% low calcium PD solution with standard 132 mmol/L Na and osmolarity of 344 mOsmol/L)” NCT06872645 ↗4“Physioneal 35 or 40 (including Clear-Flex bag), Fixioneal 35 or 40, Dianeal or Dianeal Low Calcium have 1.36%, 2.27% or 3.86% glucose” NCT03994471 ↗ |
| Known as | Dianeal Low Calcium | “Physioneal 35 or 40 (including Clear-Flex bag), Fixioneal 35 or 40, Dianeal or Dianeal Low Calcium have 1.36%, 2.27% or 3.86% glucose” NCT03994471 ↗ |